Search Results - "FLEURY, Hervé"

Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update by Bennett, Diane E, Camacho, Ricardo J, Otelea, Dan, Kuritzkes, Daniel R, Fleury, Hervé, Kiuchi, Mark, Heneine, Walid, Kantor, Rami, Jordan, Michael R, Schapiro, Jonathan M, Vandamme, Anne-Mieke, Sandstrom, Paul, Boucher, Charles A B, van de Vijver, David, Rhee, Soo-Yon, Liu, Tommy F, Pillay, Deenan, Shafer, Robert W

“…Programs that monitor local, national, and regional levels of transmitted HIV-1 drug resistance inform treatment guidelines and provide feedback on the success…”
Get full text

Seropositivity to herpes simplex virus antibodies and risk of Alzheimer's disease: a population-based cohort study by Letenneur, Luc, Pérès, Karine, Fleury, Hervé, Garrigue, Isabelle, Barberger-Gateau, Pascale, Helmer, Catherine, Orgogozo, Jean-Marc, Gauthier, Serge, Dartigues, Jean-François

“…Herpes Simplex Virus (HSV) infection has been proposed as a possible risk factor of Alzheimer's Disease (AD) notably because it is neurotropic, ubiquitous in…”
Get full text

Prevalence and evolution of low frequency HIV drug resistance mutations detected by ultra deep sequencing in patients experiencing first line antiretroviral therapy failure by Vandenhende, Marie-Anne, Bellecave, Pantxika, Recordon-Pinson, Patricia, Reigadas, Sandrine, Bidet, Yannick, Bruyand, Mathias, Bonnet, Fabrice, Lazaro, Estibaliz, Neau, Didier, Fleury, Hervé, Dabis, François, Morlat, Philippe, Masquelier, Bernard

“…Clinical relevance of low-frequency HIV-1 variants carrying drug resistance associated mutations (DRMs) is still unclear. We aimed to study the prevalence of…”
Get full text

Sanger and Next-Generation Sequencing data for characterization of CTL epitopes in archived HIV-1 proviral DNA by Tumiotto, Camille, Riviere, Lionel, Bellecave, Pantxika, Recordon-Pinson, Patricia, Vilain-Parce, Alice, Guidicelli, Gwenda-Line, Fleury, Hervé

“…One of the strategies for curing viral HIV-1 is a therapeutic vaccine involving the stimulation of cytotoxic CD8-positive T cells (CTL) that are Human…”
Get full text

Contribution of next generation sequencing to early detection of cytomegalovirus UL97 emerging mutants and viral subpopulations analysis in kidney transplant recipients by Garrigue, Isabelle, Moulinas, Rémi, Pinson-Recordon, Patricia, Delacour, Marie-Laure, Essig, Marie, Kaminski, Hannah, Rerolle, Jean-Philippe, Merville, Pierre, Fleury, Hervé, Alain, Sophie

“…Highlights • CMV mutations emergence and persistence must be followed in transplanted patients. • UL97 L595S mutation is one of the more frequent mutations…”
Get full text

Prediction of Cytomegalovirus (CMV) Plasma Load from Evaluation of CMV Whole-Blood Load in Samples from Renal Transplant Recipients by GARRIGUE, Isabelle, DOUSSAU, Adélaïde, ASSELINEAU, Julien, BRICOUT, Hélène, COUZI, Lionel, RIO, Catherine, MERVILLE, Pierre, FLEURY, Hervé, LAFON, Marie-Edith, THIDBAUT, Rodolphe

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Estimating HIV-1 Genetic Diversity in Brazil Through Next-Generation Sequencing by Alves, Brunna M, Siqueira, Juliana D, Prellwitz, Isabel M, Botelho, Ornella M, Da Hora, Vanusa P, Sanabani, Sabri, Recordon-Pinson, Patrícia, Fleury, Hervé, Soares, Esmeralda A, Soares, Marcelo A

“…Approximately 36.7 million people were living with the human immunodeficiency virus (HIV) at the end of 2016 according to UNAIDS, representing a global…”
Get full text

Provir/Latitude 45 study: A step towards a multi-epitopic CTL vaccine designed on archived HIV-1 DNA and according to dominant HLA I alleles by Tumiotto, Camille, Alves, Bruna M, Recordon-Pinson, Patricia, Jourdain, Marine, Bellecave, Pantxika, Guidicelli, Gwenda-Line, Visentin, Jonathan, Bonnet, Fabrice, Hessamfar, Mojdan, Neau, Didier, Sanchez, Jorge, Brander, Christian, Sajadi, Mohammad, Eyzaguirre, Lindsay, Soares, Esmeralda A, Routy, Jean-Pierre, Soares, Marcelo A, Fleury, Hervé

“…One of the approaches by which the scientific community is seeking to cure HIV is the use of therapeutic vaccination. Previous studies have highlighted the…”
Get full text

Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy by PEUCHANT, Olivia, THIEBAUT, Rodolphe, CAPDEPONT, Sophie, LAVIGNOLLE-AURILLAC, Valérie, NEAU, Didier, MORLAT, Philippe, DABIS, Francois, FLEURY, Hervé, MASQUELIER, Bernard

“…The transmission of drug-resistant HIV-1 can impair the virological response to antiretroviral therapy. Minority-resistant variants have been detected in acute…”
Get full text

ART-Treated Patients Exhibit an Adaptive Immune Response against the HFVAC Peptides, a Potential HIV-1 Therapeutic Vaccine (Provir/Latitude45 Study) by Fleury, Hervé, Caldato, Sabrina, Recordon-Pinson, Patricia, Thebault, Patricia, Guidicelli, Gwenda-Line, Hessamfar, Mojgan, Morlat, Philippe, Bonnet, Fabrice, Visentin, Jonathan

“…We proposed a new HIV-1 therapeutic vaccine based on conserved cytotoxic T lymphocyte (CTL) epitopes of archived HIV-1 DNA according to their affinity to the…”
Get full text

Resistance mutations and CTL epitopes in archived HIV-1 DNA of patients on antiviral treatment: toward a new concept of vaccine by Papuchon, Jennifer, Pinson, Patricia, Lazaro, Estibaliz, Reigadas, Sandrine, Guidicelli, Gwendaline, Taupin, Jean-Luc, Neau, Didier, Fleury, Hervé

“…Eleven patients responding successfully to first-line antiretroviral therapy (ART) were investigated for proviral drug resistance mutations (DRMs) in RT by…”
Get full text

HIV and SARS-CoV-2 Pathogenesis and Vaccine Development by Fleury, Herve

“…Although both HIV and SARS-CoV-2 are associated with pandemics, they are transmitted differently [...]…”
Get full text

Association between IgM anti-herpes simplex virus and plasma amyloid-beta levels by Féart, Catherine, Helmer, Catherine, Fleury, Hervé, Béjot, Yannick, Ritchie, Karen, Amouyel, Philippe, Schraen-Maschke, Susanna, Buée, Luc, Lambert, Jean-Charles, Letenneur, Luc, Dartigues, Jean-François

“…Herpes simplex virus (HSV) reactivation has been identified as a possible risk factor for Alzheimer's disease (AD) and plasma amyloid-beta (Aβ) levels might be…”
Get full text

HDV Can Constrain HBV Genetic Evolution in HBsAg: Implications for the Identification of Innovative Pharmacological Targets by Colagrossi, Luna, Salpini, Romina, Scutari, Rossana, Carioti, Luca, Battisti, Arianna, Piermatteo, Lorenzo, Bertoli, Ada, Fabeni, Lavinia, Minichini, Carmine, Trimoulet, Pascale, Fleury, Hervé, Nebuloso, Elena, De Cristofaro, Maria, Cappiello, Giuseppina, Spanò, Alberto, Malagnino, Vincenzo, Mari, Terenzio, Barlattani, Angelo, Iapadre, Nerio, Lichtner, Miriam, Mastroianni, Claudio, Lenci, Ilaria, Pasquazzi, Caterina, De Sanctis, Giuseppe Maria, Galeota Lanza, Alfonso, Stanzione, Maria, Stornaiuolo, Gianfranca, Marignani, Massimo, Sarmati, Loredana, Andreoni, Massimo, Angelico, Mario, Ceccherini-Silberstein, Francesca, Perno, Carlo-Federico, Coppola, Nicola, Svicher, Valentina

“…Chronic HBV + HDV infection is associated with greater risk of liver fibrosis, earlier hepatic decompensation, and liver cirrhosis hepatocellular carcinoma…”
Get full text

Fatal case of enterovirus 71 infection and rituximab therapy, france, 2012 by Kassab, Somar, Saghi, Tahar, Boyer, Alexandre, Lafon, Marie-Edith, Gruson, Didier, Lina, Bruno, Fleury, Hervé, Schuffenecker, Isabelle

Get full text

Kinetics of HIV-1 CTL epitopes recognized by HLA I alleles in HIV-infected individuals at times near primary infection: the Provir/Latitude45 study by Papuchon, Jennifer, Pinson, Patricia, Guidicelli, Gwenda-Line, Bellecave, Pantxika, Thomas, Réjean, LeBlanc, Roger, Reigadas, Sandrine, Taupin, Jean-Luc, Baril, Jean Guy, Routy, Jean Pierre, Wainberg, Mark, Fleury, Hervé

“…In patients responding successfully to ART, the next therapeutic step is viral cure. An interesting strategy is antiviral vaccination, particularly involving…”
Get full text

Molecular characterization of non-B HIV type 1 isolates from patients of a department of infectious diseases, University Hospital of Bordeaux, France, 1989-2009 by Javaugue, François-Charles, Recordon-Pinson, Patricia, Decoin, Madeleine, Masquelier, Bernard, Cazanave, Charles, Neau, Didier, Dupon, Michel, Ragnaud, Jean-Marie, Fleury, Hervé J

“…The molecular characterization of non-B HIV type 1 subtypes and the sociodemographic baseline characteristics have been studied for 114 non-B HIV-1-infected…”
Get more information

Reduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central Africans by Bégaud, Evélyne, Chartier, Loïc, Marechal, Valéry, Ipero, Julienne, Léal, Josianne, Versmisse, Pierre, Breton, Guillaume, Fontanet, Arnaud, Capoulade-Metay, Corinne, Fleury, Hervé, Barré-Sinoussi, Françoise, Scott-Algara, Daniel, Pancino, Gianfranco

“…Environmentally driven immune activation was suggested to contribute to high rates of HIV-1 infection in Africa. We report here a study of immune activation…”
Get full text

HIV-1 antiretroviral drug resistance in recently infected patients in Abidjan, Côte d'Ivoire: A 4-year survey, 2002-2006 by Toni, Thomas d'Aquin, Masquelier, Bernard, Minga, Albert, Anglaret, Xavier, Danel, Christine, Coulibaly, Ali, Chenal, Henri, Dabis, François, Salamon, Roger, Fleury, Hervé J

“…We performed HIV-1 drug resistance genotypic analysis of viral isolates from 100 antiretroviral (ARV)-naive, recently HIV-1-infected (between 2002 and 2006)…”
Get more information

Analysis of RT sequences of subtype C HIV-type 1 isolates from indian patients at failure of a first-line treatment according to clinical and/or immunological WHO guidelines by Deshpande, Alaka, Jeannot, Anne Cécile, Schrive, Marie Hélène, Wittkop, Linda, Pinson, Patricia, Fleury, Hervé J

“…The reverse transcriptase (RT) sequences of HIV-1 subtype C isolates from Indian patients at failure (according to WHO clinical or immunological criteria) of a…”
Get more information